Esketamine Hydrochloride — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

5 Recruiting

4 Completed trials

10 Sponsors

8 Countries

Phase III

Phase III/IV

Phase IV

Phase I (Other)

Phase III: 2 Phase II: 1 Phase III/IV: 2 Phase IV: 5 Phase I (Other): 2

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Complex regional pain syndrome 1 Schizophrenia 1 Schizoaffective disorder depressive type 1 Negative symptoms in schizophrenia 1 Major depression 1

Sponsors using this IMP

Medical University Of Vienna 3 Rigshospitalet 2 Amsterdam UMC Stichting 1 Centre Hospitalier Universitaire De Nantes 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Ketabon GmbH 1 Pohjois-Pohjanmaan hyvinvointialue 1 Reinier de Graaf Groep 1 University Medical Center Utrecht 1 University Of Oulu 1

All trials

12 total

A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised

2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
Premedication for less invasive surfactant administration (LISA-Med) Pending

2025-520492-10-00 Phase IV 1 country Pohjois-Pohjanmaan hyvinvointialue; University Of Oulu
Pain Relief via Mouthwash or Intravenous Infusion in Mouth Inflammation after Chemotherapy Pending

2025-522545-22-00 Phase II 1 country Amsterdam UMC Stichting
Ketamine sedation as neuroprotective agent following out-of-hospital cardiac arrest Recruiting

2024-515987-29-00 Phase III/IV 1 country Rigshospitalet
EASYlight study Recruiting

2023-508417-16-00 Phase IV 1 country Reinier de Graaf Groep
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury (KETA-BID) Recruiting

2024-515315-22-00 Phase IV 1 country Rigshospitalet
Ketamine study Recruiting

2024-519097-39-01 Phase III 1 country Medical University Of Vienna
Investigation of neurobiological mechanisms of antidepressant action of ketamine using neuroimaging Recruiting

2024-519234-23-00 Phase I (Other) 1 country Medical University Of Vienna
A prospective randomized, single blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital an… Ended

2024-512210-18-00 Phase III/IV 1 country Medical University Of Vienna
KetCRPS-2 Ended

2024-511877-31-00 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
ESKAPE randomized controlled double-blind study: ESKetamine low-dose versus ketamine low-dose for Severe Acute Pain in the Emergency Departm… Ended

2024-518733-29-00 Phase IV 1 country Centre Hospitalier Universitaire De Nice
A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of anti… Ended

2023-503971-45-00 Phase I (Other) 1 country Ketabon GmbH

Showing 1–12 of 12 trials

← All drugs A–Z